Loading
NYSEHealthcareMedical - Devices
Latest quote
$98.07
−$0.85 · -0.86%
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Previous close
$98.07
−$0.85 · -0.86%
Regular session · ET · Market data may be delayed.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Day range
Current $98.07
52-week range
Current $98.07
Regular session · ET · Market data may be delayed.
AI-powered factor overview
GoAI Score
Buy
Favorable setup — positive multi-factor alignment
Valuation
81
Deep Value
Sentiment
48
Mixed
Risk
28
Moderate Risk
Momentum
47
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Zimmer Biomet Holdings, Inc. engages in the design, manufacture, and marketing of orthopedic reconstructive products. The firm also offers sports medicine, biologics, extremities, and trauma products, spine, craniomaxillofacial, and thoracic products, office-based technologies, dental implants, and related surgical products. It operates through the following geographical segments: Americas, Europe Middle East and Africa, and Asia Pacific. The Americas segment consists of the U.S. and includes other North, Central and South American markets. The Europe Middle East and Africa segment includes France, Germany, Italy, Spain, and the United Kingdom. The Asia Pacific segment refers to the key markets such as Japan, China, Australia, New Zealand, Korea, Taiwan, India, Thailand, Singapore, Hong Kong, and Malaysia. The company was founded by Justin O. Zimmer in 1927 and is headquartered in Warsaw, IN.
Day range
Current $98.07
52-week range
Current $98.07
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 8.23B USD | 7.68B USD | 7.39B USD | 6.94B USD | 6.83B USD |
| Cost of goods sold | 3.16B USD | 2.19B USD | 2.08B USD | 2.02B USD | 1.96B USD |
| Gross profit | 5.07B USD | 5.49B USD | 5.31B USD | 4.92B USD | 4.87B USD |
| Research and development | 458.5M USD | 437.4M USD | 458.7M USD | 406M USD | 435.8M USD |
| Selling, general, and administrative | 3.25B USD | 2.93B USD | 2.84B USD | 2.76B USD | 2.84B USD |
| Operating expenses | 3.71B USD | 4.2B USD | 4.03B USD | 4.22B USD | 4.01B USD |
| Interest expense | 292.8M USD | 218M USD | 201.2M USD | 164.8M USD | 208.4M USD |
| Depreciation and amortization | 1.09B USD | 996.3M USD | 951.7M USD | 926.4M USD | 937.7M USD |
| Operating income | 1.36B USD | 1.29B USD | 1.28B USD | 696.3M USD | 860.3M USD |
| Net income | 705.2M USD | 903.8M USD | 1.02B USD | 231.4M USD | 401.6M USD |
Company facts updated Sep 6, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Average target
$103.11
5.14% upsideFunds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI578.61M0.03%2.3T USD0.03%$379.73-0.32%
Vanguard S&P 500 ETFVOO476.86M0.03%1.7T USD0.03%$708.01-0.38%
VanEck Morningstar Wide Moat ETFMOAT297.21M2.43%12.17B USD0.46%$111.73-1.39%
iShares Core S&P 500 ETFIVV255.54M0.03%878.68B USD0.03%$773.92-0.41%
State Street SPDR S&P 500 ETFSPY234.49M0.03%817.33B USD0.09%$770.19-0.39%
Invesco S&P 500 Equal Weight ETFRSP211.23M0.21%100.53B USD0.20%$219-0.48%
Vanguard Morningstar Small-Cap ETFVB208.79M0.11%183.4B USD0.03%$300.01+0.05%
Vanguard Morningstar Mid-Cap ETFVO196.64M0.09%224.7B USD0.03%$82.28-0.20%Vanguard Morningstar Total Stock Market ETFVTIVanguard S&P 500 ETFVOOVanEck Morningstar Wide Moat ETFMOATiShares Core S&P 500 ETFIVVState Street SPDR S&P 500 ETFSPYInvesco S&P 500 Equal Weight ETFRSPVanguard Morningstar Small-Cap ETFVBVanguard Morningstar Mid-Cap ETFVOAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
